In-vitro diagnostic (IVD) solutions player Zhejiang Pushikang Biotechnology Co., Ltd. has pocketed ‘millions of dollars’ in a Series B round of financing led by YuanBio Venture Capital (also known as bioVenture), according to an announcement on Wednesday.
YuanBio Venture Capital is an early and growth-stage life science and healthcare investment focused venture capital firm.
